BioCube Valuation
| BICB Stock | USD 0.0002 0.00 0.00% |
BioCube seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of BioCube from analyzing the firm fundamentals such as Current Valuation of 3.84 M, shares owned by institutions of 0.07 %, and Price To Sales of 0 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioCube's price fluctuation is very steady at this time. Calculation of the real value of BioCube is based on 3 months time horizon. Increasing BioCube's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BioCube is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioCube Pink Sheet. However, BioCube's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.68E-4 | Hype 2.0E-4 | Naive 2.0E-4 |
The real value of BioCube Pink Sheet, also known as its intrinsic value, is the underlying worth of BioCube Company, which is reflected in its stock price. It is based on BioCube's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioCube's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioCube helps investors to forecast how BioCube pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioCube more accurately as focusing exclusively on BioCube's fundamentals will not take into account other important factors: BioCube Total Value Analysis
BioCube is currently forecasted to have valuation of 3.84 M with market capitalization of 3.14 M, debt of 1.03 M, and cash on hands of 39. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioCube fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.84 M | 3.14 M | 1.03 M | 39 |
BioCube Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of BioCube suggests not a very effective usage of assets in January.BioCube Ownership Allocation
BioCube holds a total of 44.84 Million outstanding shares. Almost 99.93 percent of BioCube outstanding shares are held by general public with 0.069 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioCube Profitability Analysis
Net Loss for the year was (534.8 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioCube's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioCube and how it compares across the competition.
About BioCube Valuation
The pink sheet valuation mechanism determines BioCube's current worth on a weekly basis. Our valuation model uses a comparative analysis of BioCube. We calculate exposure to BioCube's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioCube's related companies.BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.
8 Steps to conduct BioCube's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioCube's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioCube's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioCube's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioCube's revenue streams: Identify BioCube's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioCube's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioCube's growth potential: Evaluate BioCube's management, business model, and growth potential.
- Determine BioCube's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioCube's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BioCube Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -3.4 M |
Complementary Tools for BioCube Pink Sheet analysis
When running BioCube's price analysis, check to measure BioCube's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCube is operating at the current time. Most of BioCube's value examination focuses on studying past and present price action to predict the probability of BioCube's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCube's price. Additionally, you may evaluate how the addition of BioCube to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |